| News and New Technologies from the Buyer's Guide for Life Scientists |
Sponsored by Applied Stemcell
Teratoma Formation Analysis. Applied StemCell Inc. offers full services on in vivo pluripotency characterization of human and mouse embryonic stem cells/induced pluripotent stem cells (ESCs/iPSCs) by teratoma formation analysis. Using a new kidney capsule injection technique, we have achieved over 90% success rate in producing teratomas with all three germ layers. This new technique is especially suitable for cells that are hard to obtain. The cell number is 0.5-1 million per site comparing to 3-5 million in a subcutaneous injection. The growth of tumors is much faster, with most tumors forming within 4 weeks.
more...
|
|
|
|
| Featured Article
|
 Spectrophotometry
Spectrophotometry is a technology that has long been considered mature, and advances in instrumentation tend to focus on fine-tuning the technical details, such as...more...
|
|
|
|
|
|
| Promotion
|
Receive a 20% Discount on Hematology Reagents for the Study of Plasmin Activation
For a limited time, Cell Sciences is offering a 20% discount on selected products useful in the investigation of plasmin activation. These include PAI-1, tPA, uPA, uPAR, Vitronectin and related proteins and ELISA kits. Plasminogen Activator Inhibitor 1 (PAI-1) plays a key role in fibrinolysis through its regulation of Tissue-type (tPA) and Urokinase-type Plasminogen Activators (uPA). Plasminogen is the inactive zymogen of plasmin, the protease responsible for degrading fibrin. The intricacies of the PAI-1-Plasminogen Activator-Plasmin system and its regulation are being investigated in renal and cardiovascular disease, in addition to inflammation, angiogenesis, and cancer.More Information
|
|
|
| Events |
|
Featured Event: SBS 16th Annual Conference & Exhibition
April 11 - April 15, 2010
Advancing the Science of Drug Discovery will include feature presentations, short courses and workshops emphasizing the growing integration of the biomolecular sciences and their influence on drug research and development. Some 175 bio-tech innovators will provide breaking news, demonstrations of emerging technologies, and new products and services in the exhibit hall.
more...
High Throughput Screening
April 26 - April 27, 2010
SMi's industry-leading High Throughput Screening conference returns for its fourth year. The theme of this year's conference will be how to lead HTS down an intelligent route towards lead generation, and will be discussed and debated by senior representatives from industry and the growing academic HTS sector.
more...
|
|
|
|
| Back to Top |
